IMMUNOPRECIPITATION AND OPSONIC CROSS-REACTION BETWEEN TYPE-14 PNEUMOCOCCUS AND GROUP-B STREPTOCOCCUS TYPE m
- 1 January 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 313 (8107) , 75-77
- https://doi.org/10.1016/s0140-6736(79)90064-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.The Journal of Experimental Medicine, 1978
- Immunogenicity of polysaccharides from type III, group B Streptococcus.Journal of Clinical Investigation, 1978
- Pneumococcal Infection and Pneumococcal VaccineNew England Journal of Medicine, 1977
- Structural studies on the specific type-14 pneumococcal polysaccharideCarbohydrate Research, 1977
- Summary of the Workshop on Perinatal Infections Due to Group B StreptococcusThe Journal of Infectious Diseases, 1977
- Correlation of Maternal Antibody Deficiency with Susceptibility to Neonatal Group B Streptococcal InfectionNew England Journal of Medicine, 1976
- Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.The Journal of Experimental Medicine, 1976
- Pneumococcal septicemia and meningitis in the neonateThe Journal of Pediatrics, 1975
- VARIATION IN THE GROUP-SPECIFIC CARBOHYDRATE OF GROUP A STREPTOCOCCIThe Journal of Experimental Medicine, 1955